-- Aura Biosciences (AURA) 週一宣布，已完成近3,960萬股普通股及預付認股權證的承銷公開發行定價。該認股權證可購買至多380萬股普通股，行使價為每份0.00001美元，預計募集資金總額為2.603億美元。 該公司表示，已授予承銷商30天的超額配售選擇權，可額外購買至多650萬股普通股。發行價為每股6美元，每份預付認股權證5.99999美元。 此次發行預計將於週二左右完成。 Aura表示，計劃將募集資金淨額中的2.051億美元，連同現有現金、現金等價物和有價證券，用於推進其臨床項目。剩餘資金預計將用於以每股5.64美元的價格從Matrix Capital Management Master Fund回購至多692萬股股票。 週一，Aura Biosciences的股價上漲了近17%。
Price: $8.19, Change: $+1.18, Percent Change: +16.83%
The Canadian government tabled its Spring Economic Update (SEU) last week, substantially revising down deficit projections for 2025, with the medium-term outlook slightly improving, said Nomura.Debt-to-GDP projections were also revised modestly lower owing to lower debt levels and a stronger growth profile over the forecast horizon, noted the bank in a note published last week.The government announced the creation of a sovereign wealth fund, with an initial endowment of $25 billion, with more details expected in the coming months.Overall, the SEU suggests Canada's fiscal position remains strong, leaving the government with additional headroom to support the economy if the CUSMA negotiations falter, while allowing the Bank of Canada to remain focused on inflation risks, stated Nomura.The SEU contained few surprises, according to the bank. The government revised down deficit projections for 2025, while the medium-term profile improved slightly.
Electromagnetic Geoservices (EMGS.OL) appointed Glenn Pettersen as interim chief executive after the company completed the sale of its operations and assets to P-2 Riggs Capital in April.The Norwegian geophysical services company on Monday said local law requires the service of a CEO even if the business is no longer actively operating, has no employees, and holds no material assets.
Estee Lauder's (EL) turnaround continues, but headwinds from the Middle East conflict could still weigh on fiscal Q4 results, RBC Capital Markets said in a Monday note.Estee Lauder reported fiscal Q3 adjusted earnings of $0.91 per diluted share, up from $0.65 a year earlier, as net sales increased to $3.71 billion from $3.55 billion. The company also raised its fiscal 2026 adjusted EPS outlook to between $2.35 and $2.45, from $2.05 to $2.25 previously.Business disruptions from the Middle East conflict are estimated to have a negative impact of $0.07 to the company's fiscal 2026 EPS and $0.06 dilutive to fiscal Q4 EPS, the investment firm said. RBC noted that Estee Lauder's updated outlook "assumes no deterioration" in the Middle East beyond May, along with current market conditions.The guidance is still "reasonable" and positions Estee Lauder to hit its targets, RBC added.RBC Capital Markets has an outperform rating and $111 price target on Estee Lauder.Price: $81.35, Change: $+2.05, Percent Change: +2.59%